Home Newsletters Mesenchymal Cell News Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells

Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells

0
By engineering the t(11;22)(q24;q12) translocation together with a combination of SPC mutations, we generated a wide collection of immortalized cells tolerating EWSR1-FLI1 expression from primary MSC derived from an EwS patient.
[Cancer Research]
6445218 {6445218:PTAJ5P79} apa 50 1 165257 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Abstract
Exit mobile version